DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,615,156 | +3.4% | 18,602 | 0.0% | 2.57% | +8.6% |
Q2 2023 | $4,464,480 | -7.0% | 18,602 | -2.3% | 2.36% | -12.8% |
Q1 2023 | $4,799,850 | -7.0% | 19,044 | -2.1% | 2.71% | -16.5% |
Q4 2022 | $5,161,623 | -2.1% | 19,447 | -4.8% | 3.25% | -3.5% |
Q3 2022 | $5,275,000 | +1.9% | 20,423 | 0.0% | 3.37% | +11.5% |
Q2 2022 | $5,178,000 | -21.1% | 20,423 | -8.7% | 3.02% | -4.3% |
Q1 2022 | $6,565,000 | -12.6% | 22,380 | -2.0% | 3.15% | -3.9% |
Q4 2021 | $7,511,000 | +5.1% | 22,829 | -2.7% | 3.28% | -1.1% |
Q3 2021 | $7,144,000 | -7.7% | 23,465 | -18.6% | 3.32% | -3.2% |
Q2 2021 | $7,739,000 | +19.2% | 28,839 | 0.0% | 3.43% | +6.8% |
Q1 2021 | $6,491,000 | -6.5% | 28,839 | -7.7% | 3.21% | -13.6% |
Q4 2020 | $6,944,000 | +3.2% | 31,259 | 0.0% | 3.71% | -9.2% |
Q3 2020 | $6,731,000 | +15.7% | 31,259 | -5.0% | 4.09% | +8.8% |
Q2 2020 | $5,819,000 | +27.7% | 32,909 | 0.0% | 3.76% | +4.3% |
Q1 2020 | $4,555,000 | -29.1% | 32,909 | -21.4% | 3.61% | -20.3% |
Q4 2019 | $6,423,000 | +6.3% | 41,849 | 0.0% | 4.53% | -5.1% |
Q3 2019 | $6,044,000 | +1.1% | 41,849 | 0.0% | 4.77% | +7.5% |
Q2 2019 | $5,981,000 | -1.5% | 41,849 | -9.0% | 4.44% | -2.5% |
Q1 2019 | $6,074,000 | +3.7% | 46,010 | -19.0% | 4.56% | -8.9% |
Q4 2018 | $5,858,000 | -19.5% | 56,810 | -15.2% | 5.00% | +7.1% |
Q3 2018 | $7,281,000 | -7.4% | 67,010 | -15.9% | 4.67% | +5.8% |
Q2 2018 | $7,867,000 | +0.8% | 79,720 | 0.0% | 4.42% | -7.4% |
Q1 2018 | $7,805,000 | +5.5% | 79,720 | 0.0% | 4.77% | +5.3% |
Q4 2017 | $7,400,000 | +8.2% | 79,720 | 0.0% | 4.53% | +5.5% |
Q3 2017 | $6,838,000 | +21.8% | 79,720 | +19.8% | 4.29% | +17.7% |
Q2 2017 | $5,614,000 | -1.3% | 66,520 | 0.0% | 3.65% | -3.9% |
Q1 2017 | $5,689,000 | +9.9% | 66,520 | 0.0% | 3.80% | +8.2% |
Q4 2016 | $5,178,000 | +11.0% | 66,520 | +11.8% | 3.51% | +21.0% |
Q3 2016 | $4,666,000 | -22.4% | 59,520 | 0.0% | 2.90% | -23.0% |
Q2 2016 | $6,012,000 | +6.5% | 59,520 | 0.0% | 3.77% | +8.0% |
Q1 2016 | $5,646,000 | +2.1% | 59,520 | 0.0% | 3.49% | +8.7% |
Q4 2015 | $5,528,000 | -4.8% | 59,520 | -12.7% | 3.21% | -13.3% |
Q3 2015 | $5,809,000 | -16.3% | 68,170 | -15.9% | 3.70% | +16.0% |
Q2 2015 | $6,939,000 | +0.8% | 81,070 | 0.0% | 3.19% | +2.9% |
Q1 2015 | $6,883,000 | +34.5% | 81,070 | +35.8% | 3.10% | +4.4% |
Q4 2014 | $5,118,000 | +19.5% | 59,710 | +5.9% | 2.97% | +22.9% |
Q3 2014 | $4,284,000 | +57.4% | 56,380 | +63.1% | 2.42% | +19.7% |
Q2 2014 | $2,722,000 | +62.4% | 34,570 | +54.7% | 2.02% | +20.4% |
Q1 2014 | $1,676,000 | -2.8% | 22,340 | 0.0% | 1.68% | -1.6% |
Q4 2013 | $1,725,000 | +11.4% | 22,340 | 0.0% | 1.70% | +14.2% |
Q3 2013 | $1,549,000 | +11.9% | 22,340 | +2.1% | 1.49% | +2.1% |
Q2 2013 | $1,384,000 | – | 21,870 | – | 1.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |